Company intelligence / Profile preview
NuVision Biotherapies
Nottingham, Nottinghamshire, United Kingdomnu-vision.co.uk ↗
- Ownership
- Private
- Employees
- ~16
- Development stage
- Commercial
01
Overview
NuVision manufactures Omnigen, a wound dressing and grafting material made from amniotic membrane that retains natural barrier function to support healing and recovery of the ocular surface[1][5]
- Therapeutic areas
- Ophthalmology
- Modalities
- Biological wound dressingsAmniotic membrane-derived therapies
- Industry
- Biotech
02
Drug pipeline
1 asset03
Partnerships
University of Nottingham
Beyond the preview
Go deeper on NuVision Biotherapies.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on NuVision Biotherapies.